Human miR-504 antisense oligonucleotide and application thereof

A technology of mir-504 and oligonucleotides, applied in microRNAs antisense oligonucleotides, human microRNA-504 antisense oligonucleotides and its application fields, can solve the problem of poor curative effect and long-term In order to achieve the effect of inhibiting malignant proliferation, good inhibitory effect, and high specificity

Active Publication Date: 2012-08-22
SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI +1
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Moreover, these methods have their own limitations, especially for the middle-advanced and relapsed patients, and the curative effect is even worse for those with distant metastasis.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Human miR-504 antisense oligonucleotide and application thereof
  • Human miR-504 antisense oligonucleotide and application thereof
  • Human miR-504 antisense oligonucleotide and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0029] Example: Detection of antisense oligonucleotides of miR-504 on human glioblastoma cell line U87 / MG inhibitory activity

[0030] First, miR-504 antisense oligonucleotide was synthesized by Shanghai Gemma Pharmaceutical Technology Co., Ltd., the sequence is: 5'-GAUAGAGUGCAGACCAGGGUCU-3'. All the sequences used in the examples were synthesized by Shanghai Gemma Pharmaceutical Technology Co., Ltd.

[0031] Cell culture:

[0032] U87 / MG cells (human brain astroglioblastoma, purchased from the Cell Bank of the Type Culture Collection Committee of the Chinese Academy of Sciences) were purchased from Hyclone, FBS in 10% FBS-DMEM medium (DMEM (a conventional medium) (fetal bovine serum) purchased from Gibco), at 37 ° C, 5% CO 2 cultivated under conditions. Collect U87 / MG cells in good growth state, count by centrifugation, and use 2×10 3 Spread each well in a 96-well plate at 37°C, 5% CO 2 Cultivate for 24h.

[0033] Transfection:

[0034] 1) One day before transfection, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses an antisense oligonucleotide for inhibiting expression of the human microRNA-504 and application thereof. The antisense oligonucleotide specifically binds to the human miR-504, and contains sequences which are complementary to 13-22 continuous nucleotides in the following nucleotide sequence 5'-AGACCCUGGUCUGCACUCUAUC-3', especially contains the sequence 5'-GAUAGAGUGCAGACCAGGGUCU-3'. The antisense oligonucleotide of the invention can be ribonucleotide, deoxyribonucleotide or chimera of ribonucleotide and deoxyribonucleotide, and any nucleotide in the chain can be modified. The miR-504 antisense oligonucleotide of the invention can effectively inhibit expression of miR-504 in the human glioma cell, and inhibit growth and propagation of the cell, thereby effectively treating glioma and other tumours with high expression of miR-504.

Description

technical field [0001] The invention belongs to the technical field of biomedical materials and the field of medicine. Specifically, the present invention relates to a microRNAs (miRNA) antisense oligonucleotide, in particular to human microRNA-504 (human miR-504) antisense oligonucleotide and applications thereof. The antisense oligonucleotide can be complementary to human miR-504, thereby inhibiting the expression of human miR-504 to play an anti-tumor effect. The present invention also relates to a pharmaceutical composition comprising the miRNA antisense oligonucleotide. Background technique [0002] miRNAs (also known as microRNA or microRNA) are small non-coding RNAs with a length of 20-25bp, usually transcribed by RNA polymerase II (Pol II), and generally the initial product is a large cap structure (7MGpppG) and pri-miRNA (primary miRNA, primary miRNA) of polyadenylic acid tail (AAAAA). These pri-miRNAs are processed into precursor miRNAs (precursor miRNA, pre-miR...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/113A61K48/00A61P35/00A61P25/00
Inventor 丁侃张佩琢李捷沈孝坤
Owner SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap